JAGXJaguar Health, Inc.

Nasdaq jaguar.health


$ 1.24 $ -0.03 (-2.36 %)    

Monday, 19-Aug-2024 15:59:51 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 1.24
$ 1.29
$ 1.23 x 252
$ 1.24 x 400
$ 1.23 - $ 1.30
$ 0.95 - $ 31.74
513,066
na
2.91M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-24-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-22-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-11-2022 12-31-2021 10-K
12 11-17-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 04-03-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-21-2019 03-31-2019 10-Q
23 04-10-2019 12-31-2018 10-K
24 11-19-2018 09-30-2018 10-Q
25 08-13-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-09-2018 12-31-2017 10-K
28 11-20-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 02-15-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-29-2016 12-31-2015 10-K
36 11-13-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 06-26-2015 03-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Jaguar Supports Proof-Of-Concept Studies For Rare Disease Indications With Results Expected By End Of 2024 And 2025

 why-jaguar-health-jagx-stock-is-down-15

Jaguar Health shares are trading lower by 15.4% during Tuesday's session. The company reported worse-than-expected second-q...

 jaguar-health-q2-eps-404-misses-111-estimate-sales-272m-miss-394m-estimate

Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(4.04) per share which missed the analyst consensus estimate of $(1.1...

 why-jaguar-health-stock-is-crashing

Jaguar Health shares are falling Tuesday after the company announced its phase 3 OnTarget trial did not meet its primary endpoi...

 jaguar-health-announces-webcast-on-july-23-to-discuss-phase-3-ontarget-trial-results-for-crofelemer

Will Include Updates On Cancer Supportive Care Portfolio And Expansion Of Make Cancer Less Shitty Program With MCLS Ambassadors

 jaguar-health-to-present-phase-3-ontarget-trial-results-for-its-cancer-supportive-care-drug-crofelemer-on-or-before-july-23-2024

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including particip...

 jaguar-health-and-magdalena-biosciences-executes-out-license-deal-with-for-botanical-drug-candidate-for-schizophrenia

The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for s...

 whats-going-on-with-jaguar-health-stock

Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION